New coumarin-based fluorescent melatonin ligands. Design, synthesis and pharmacological characterization

New coumarin-based fluorescent melatonin ligands. Design, synthesis and pharmacological characterization Design and synthesis of 1-(2-alkanamidoethyl)-6-methoxy-7-azaindole derivatives as potent melatonin agonists New melatonin (MT1/MT2) ligands: Design and synthesis of (8,9-dihydro-7H-furo[3,2-f]chromen-1-yl) derivatives Melatonergic ligands: Design, synthesis and pharmacological evaluation of novel series of naphthofuranic derivatives Synthesis and pharmacological evaluation of 1,2,3,4-tetrahydropyrazino[1,2-a]indole and 2-[(phenylmethylamino)methyl]-1H-indole analogues as novel melatoninergic ligands Synthesis and pharmacological evaluation of pentacyclic 6a,7-dihydrodiindole and 2,3-dihydrodiindole derivatives as novel melatoninergic ligands 1,6-Dihydro-2H-indeno[5,4-b]furan Derivatives: Design, Synthesis, and Pharmacological Characterization of a Novel Class of Highly Potent MT₂-Selective Agonists Synthesis and Structure−Affinity−Activity Relationships of Novel Benzofuran Derivatives as MT₂ Melatonin Receptor Selective Ligands Design and Validation of the First Family of Photo-Activatable Ligands for Melatonin Receptors 2-[(1,3-Dihydro-2H-isoindol-2-yl)methyl]melatonin – a novel MT2-selective melatonin receptor antagonist